COSCIENS Biopharma Overview
COSCIENS Biopharma Discounted Cash Flow
DCF Analysis for AEZS.
Get informed when a big investor buys or sells
+ FollowFair Value
$3.61
Current Fair Value
$3.61
↓ 36.9% Downside
Overvalued by 36.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison